These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12153194)

  • 1. Synthesis of lipophilic aldehydes and study of their inhibition effect on human digestive lipases.
    Kotsovolou S; Verger R; Kokotos G
    Org Lett; 2002 Aug; 4(16):2625-8. PubMed ID: 12153194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterically hindered triacylglycerol analogues as potent inhibitors of human digestive lipases.
    Constantinou-Kokotou V; Magrioti V; Verger R
    Chemistry; 2004 Mar; 10(5):1133-40. PubMed ID: 15007804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-2-oxo amide triacylglycerol analogues: a novel class of potent human gastric lipase inhibitors.
    Kotsovolou S; Chiou A; Verger R; Kokotos G
    J Org Chem; 2001 Feb; 66(3):962-7. PubMed ID: 11430119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digestive lipases: from three-dimensional structure to physiology.
    Miled N; Canaan S; Dupuis L; Roussel A; Rivière M; Carrière F; de Caro A; Cambillau C; Verger R
    Biochimie; 2000 Nov; 82(11):973-86. PubMed ID: 11099794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel trifluoromethyl ketones as potent gastric lipase inhibitors.
    Kokotos G; Kotsovolou S; Verger R
    Chembiochem; 2003 Jan; 4(1):90-5. PubMed ID: 12512081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 2-Oxo amide triacylglycerol analogues and study of their inhibition effect on pancreatic and gastric lipases.
    Kokotos G; Verger R; Chiou A
    Chemistry; 2000 Nov; 6(22):4211-7. PubMed ID: 11128286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human gastric and pancreatic lipases by chiral alkylphosphonates. A kinetic study with 1,2-didecanoyl-sn-glycerol monolayer.
    Cavalier JF; Ransac S; Verger R; Buono G
    Chem Phys Lipids; 1999 Jul; 100(1-2):3-31. PubMed ID: 10640192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the discriminative inhibition of mammalian digestive lipases by 3-phenyl substituted 1,3,4-oxadiazol-2(3H)-ones.
    Point V; Pavan Kumar KV; Marc S; Delorme V; Parsiegla G; Amara S; Carrière F; Buono G; Fotiadu F; Canaan S; Leclaire J; Cavalier JF
    Eur J Med Chem; 2012 Dec; 58():452-63. PubMed ID: 23153815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals.
    Carrière F; Renou C; Lopez V; De Caro J; Ferrato F; Lengsfeld H; De Caro A; Laugier R; Verger R
    Gastroenterology; 2000 Oct; 119(4):949-60. PubMed ID: 11040182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipases and lipolysis in the human digestive tract: where do we stand?
    Armand M
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):156-64. PubMed ID: 17285003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases.
    Fernandez S; Rodier JD; Ritter N; Mahler B; Demarne F; Carrière F; Jannin V
    Biochim Biophys Acta; 2008 Aug; 1781(8):367-75. PubMed ID: 18571509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triacylglycerols based on 2-(N-tert-butoxycarbonylamino)oleic acid are potent inhibitors of pancreatic lipase.
    Magrioti V; Verger R; Constantinou-Kokotou V
    J Med Chem; 2004 Jan; 47(2):288-91. PubMed ID: 14711301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digestive lipases: inactivation by phosphonates.
    Marguet F; Cudrey C; Verger R; Buono G
    Biochim Biophys Acta; 1994 Jan; 1210(2):157-66. PubMed ID: 8280765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis.
    Point V; Bénarouche A; Zarrillo J; Guy A; Magnez R; Fonseca L; Raux B; Leclaire J; Buono G; Fotiadu F; Durand T; Carrière F; Vaysse C; Couëdelo L; Cavalier JF
    Eur J Med Chem; 2016 Nov; 123():834-848. PubMed ID: 27543878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent inhibition of digestive lipases by chiral phosphonates.
    Cavalier JF; Buono G; Verger R
    Acc Chem Res; 2000 Sep; 33(9):579-89. PubMed ID: 10995195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and study of a lipophilic alpha-keto amide inhibitor of pancreatic lipase.
    Chiou A; Markidis T; Constantinou-Kokotou V; Verger R; Kokotos G
    Org Lett; 2000 Feb; 2(3):347-50. PubMed ID: 10814319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic routes and lipase-inhibiting activity of long-chain alpha-keto amides.
    Chiou A; Verger R; Kokotos G
    Lipids; 2001 May; 36(5):535-42. PubMed ID: 11432468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro lipolysis by human pancreatic lipase is specifically abolished by its inactive forms.
    Miled N; Berti-Dupuis L; Riviere M; Carrière F; Verger R
    Biochim Biophys Acta; 2003 Feb; 1645(2):241-6. PubMed ID: 12573254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors.
    Tamura SY; Weinhouse MI; Roberts CA; Goldman EA; Masukawa K; Anderson SM; Cohen CR; Bradbury AE; Bernardino VT; Dixon SA; Ma MG; Nolan TG; Brunck TK
    Bioorg Med Chem Lett; 2000 May; 10(9):983-7. PubMed ID: 10853674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dog and human gastric lipases by enantiomeric phosphonate inhibitors: a structure-activity study.
    Miled N; Roussel A; Bussetta C; Berti-Dupuis L; Rivière M; Buono G; Verger R; Cambillau C; Canaan S
    Biochemistry; 2003 Oct; 42(40):11587-93. PubMed ID: 14529268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.